Solutions for rapid development and manufacturing responses to COVID-19 and other public health threats.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
The novel coronavirus SARS-CoV-2 (COVID-19) has impacted many aspects of the daily lives of people around the globe, stressing healthcare and social systems and putting biotechnology at the forefront of this pandemic. Critical to the response to the pandemic is the ability to rapidly develop, scale, and manufacture novel, and effective, vaccines and therapeutics. Leveraging the lessons learned from the successful and ongoing production of early phase clinical trial material, Emergent is partnering with commercial and government teams to scale up and manufacture material capable of supporting late-stage clinical trials, as well as supplying material to support US and global efforts to fight this pandemic. Dr. Rick Welch will share lessons learned from developing drugs to treat people during epidemics and pandemics, such as COVID-19, and best practices for success in this unprecedented time.

Speaker - Richard W. Welch, Ph.D., Vice President Development Services, Emergent BioSolutions
Sponsored By